Diagnostic accuracy of prostate-specific antigen below 4 ng/mL as a cutoff for diagnosing prostate cancer in a hospital setting: A systematic review and meta-analysis

PURPOSE: A prostate-specific antigen (PSA) cutoff of 4 ng/mL has been widely used for prostate cancer screening in population-based settings. However, the accuracy of PSA below 4 ng/mL as a cutoff for diagnosing prostate cancer in a hospital setting is inconclusive. We systematically reviewed the ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Yan, Jung, Jae Hung, Han, Woong Kyu, Hwang, Eu Chang, Nho, Yoonmi, Lee, Narae, Yun, Ji Eun, Lee, Kwang Suk, Lee, Sang Hyub, Lee, Hakmin, Yu, Su-Yeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2022
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091828/
https://www.ncbi.nlm.nih.gov/pubmed/35534215
http://dx.doi.org/10.4111/icu.20210429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091828/
https://www.ncbi.nlm.nih.gov/pubmed/35534215
http://dx.doi.org/10.4111/icu.20210429

Ejemplares similares